Search

Eurofins Scientific SE

Geschlossen

72.78 1.53

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

71.68

Max

74.26

Schlüsselkennzahlen

By Trading Economics

Einkommen

123M

Verkäufe

1.8B

KGV

Branchendurchschnitt

29.577

21.746

EPS

1.16

Dividendenrendite

0.97

Gewinnspanne

6.827

Angestellte

65,000

EBITDA

409M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+1.52% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

0.97%

4.48%

Nächstes Ergebnis

25. Feb. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

12B

Vorheriger Eröffnungskurs

71.25

Vorheriger Schlusskurs

72.78

Technischer Score

By Trading Central

Vertrauen

Weak Bearish Evidence

Eurofins Scientific SE Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

12. Jan. 2026, 23:54 UTC

Market Talk

CBA Could Underperform Again in 2026 -- Market Talk

12. Jan. 2026, 23:48 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

12. Jan. 2026, 23:48 UTC

Market Talk

Nikkei May Rise on Weaker Yen -- Market Talk

12. Jan. 2026, 23:43 UTC

Market Talk

Gold Edges Lower on Likely Technical Correction -- Market Talk

12. Jan. 2026, 23:18 UTC

Akquisitionen, Fusionen, Übernahmen

Paramount Sues Warner Bros., Plans Proxy Fight. The Ellisons Aren't Giving Up. -- Barrons.com

12. Jan. 2026, 21:56 UTC

Market Talk

Light & Wonder Gets Positive Outcome From Lawsuit -- Market Talk

12. Jan. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

12. Jan. 2026, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

12. Jan. 2026, 21:50 UTC

Market Talk
Ergebnisse

Auto & Transport Roundup: Market Talk

12. Jan. 2026, 21:18 UTC

Market Talk

Global Equities Roundup: Market Talk

12. Jan. 2026, 21:18 UTC

Market Talk

Pfizer CEO Sees Large Cash Market for Obesity Drugs -- Market Talk

12. Jan. 2026, 20:54 UTC

Ergebnisse

Gap, Fortinet, and More Stocks That Usually Outperform After Earnings -- Barrons.com

12. Jan. 2026, 20:48 UTC

Market Talk

Oil Futures Settle Higher in Choppy Trade -- Market Talk

12. Jan. 2026, 20:33 UTC

Market Talk

U.S. Natural Gas Jumps on Colder Weather Outlook -- Market Talk

12. Jan. 2026, 20:18 UTC

Akquisitionen, Fusionen, Übernahmen

Credit Agricole Sees Banco BPM Stake Helping 2025 Net by EUR200M >ACA.FR

12. Jan. 2026, 20:18 UTC

Akquisitionen, Fusionen, Übernahmen

Credit Agricole: European Central Bank Approves Crossing of 20% Threshold in Share Capital of Banco BPM

12. Jan. 2026, 19:39 UTC

Market Talk

J&J CEO: Trump Pact Allows Company to Focus on Core Operations -- Market Talk

12. Jan. 2026, 19:36 UTC

Market Talk

Gold and Silver Set New Records on Fed Probe -- Market Talk

12. Jan. 2026, 19:36 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

12. Jan. 2026, 19:33 UTC

Market Talk

Venezuela's 'Proven' Oil Reserves Raises Questions -- Market Talk

12. Jan. 2026, 19:24 UTC

Akquisitionen, Fusionen, Übernahmen

Dynavax: 'Party A' CEO Sent a Non-Binding $15/Shr Proposal on Dec. 23

12. Jan. 2026, 19:22 UTC

Akquisitionen, Fusionen, Übernahmen

Dynavax Files Tender Offer Recommendation Statement Related to Sanofi Deal, Mentions Talks With 'Party A'

12. Jan. 2026, 18:21 UTC

Akquisitionen, Fusionen, Übernahmen

Paramount Plans Proxy Fight to Push Hostile Warner Bid -- 2nd Update

12. Jan. 2026, 18:20 UTC

Akquisitionen, Fusionen, Übernahmen

This French Biotech Stock Surged 1,700% in 2025. Eli Lilly Is Taking an Interest. -- Barrons.com

12. Jan. 2026, 18:19 UTC

Market Talk

Modest Canadian Economic Impact Seen from Venezuela Changes -- Market Talk

12. Jan. 2026, 18:16 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Comcast Could Unlock Value With a Spinoff of NBCUniversal Assets, Analysts Say -- Market Talk

12. Jan. 2026, 18:09 UTC

Market Talk

Global Equities Roundup: Market Talk

12. Jan. 2026, 18:09 UTC

Market Talk

Baidu's Outlook Bodes Well For Shares -- Market Talk

12. Jan. 2026, 18:01 UTC

Akquisitionen, Fusionen, Übernahmen

QXO Is Raising Another $1.8 Billion for Its M&A War Chest -- Barrons.com

12. Jan. 2026, 18:00 UTC

Market Talk

Canada's 'Breakeven' Employment Recalibrating -- Market Talk

Eurofins Scientific SE Prognose

Kursziel

By TipRanks

1.52% Vorteil

12-Monats-Prognose

Durchschnitt 70.33 EUR  1.52%

Hoch 75 EUR

Tief 64 EUR

Basierend auf 3 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Eurofins Scientific SE – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

3 ratings

2

Buy

1

Halten

0

Sell

Technischer Score

By Trading Central

54.22 / 56.82Unterstützung & Widerstand

Kurzfristig

Weak Bearish Evidence

Mittelfristig

Strong Bullish Evidence

Langfristig

Bullish Evidence

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Eurofins Scientific SE

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agroscience, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, healthcare and cosmetics, and food supplements; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include sustainability, expert services and regulatory, consumer research and sensory evaluation, audits, testing, certifications and approvals, inspections, and training courses for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, training and consulting; food irradiation and labelling, heavy metals, carbohydrates, radioactivity, nutritional analysis, microbiolody, and testing for persistent organic pollutants, veterinary drug residue, dioxins and organic contaminants, pesticides, mycotoxins, and vitamins, as well as analyses for genetic modifications. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and other services. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.
help-icon Live chat